MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $12,583,000 | -64.7% | 10,148,231 | -12.3% | 0.00% | -50.0% |
| Q1 2017 | $35,640,000 | +50097.2% | 11,572,067 | +66162.4% | 0.00% | – |
| Q4 2016 | $71,000 | -67.9% | 17,464 | -49.9% | 0.00% | – |
| Q3 2016 | $221,000 | +46.4% | 34,837 | +25.0% | 0.00% | – |
| Q2 2016 | $151,000 | +128.8% | 27,874 | +254.1% | 0.00% | – |
| Q1 2016 | $66,000 | +144.4% | 7,872 | +129.4% | 0.00% | – |
| Q4 2015 | $27,000 | -3.6% | 3,431 | +5.8% | 0.00% | – |
| Q3 2015 | $28,000 | -20.0% | 3,243 | +15.1% | 0.00% | – |
| Q2 2015 | $35,000 | +6.1% | 2,817 | +2.7% | 0.00% | – |
| Q1 2015 | $33,000 | -13.2% | 2,743 | -17.3% | 0.00% | – |
| Q4 2014 | $38,000 | +31.0% | 3,315 | 0.0% | 0.00% | – |
| Q3 2014 | $29,000 | +16.0% | 3,315 | 0.0% | 0.00% | – |
| Q2 2014 | $25,000 | +31.6% | 3,315 | -12.1% | 0.00% | – |
| Q1 2014 | $19,000 | -9.5% | 3,770 | 0.0% | 0.00% | – |
| Q4 2013 | $21,000 | +50.0% | 3,770 | 0.0% | 0.00% | – |
| Q3 2013 | $14,000 | -39.1% | 3,770 | +11.5% | 0.00% | – |
| Q2 2013 | $23,000 | – | 3,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |